Improvement in Left Ventricular Function Despite No Change in T2* with Iron Chelation in Secondary Hemochromatosis.
Prabhjot Singh
PS
Nijjar
Haree
H
Vongooru
Ashenafi
A
Tamene
Uma
U
Valeti
Carolina
C
Masri
D000328:Adult; D000741:Anemia, Aplastic / Q000150:complications* / Q000628:therapy*; D000077543:Deferiprone; D003676:Deferoxamine / Q000627:therapeutic use*; D004452:Echocardiography; D006432:Hemochromatosis / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects*; D011728:Pyridones / Q000627:therapeutic use*; D065227:Transfusion Reaction; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis* / Q000188:drug therapy*
D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone; D003676:Deferoxamine